• Image 01
  • Image 02
  • Image 03
  • Image 04
  • Image 05
  • Image 06
Need assistance? Contact Us: 1-800-255-5897

Menu

  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
  • Home
  • About Us
    • Company Overview
    • Management Team
    • Board of Directors
  • Your Loan Service Center
  • MAKE A PAYMENT
  • Business Service Center
  • Contact Us
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Catalent, Inc. Common Stock (NY:CTLT)

63.48 UNCHANGED
Last Price Updated: 7:00 PM EST, Dec 17, 2024 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 0
Open 63.48
Bid (Size) 63.00 (1)
Ask (Size) 63.50 (108)
Prev. Close 63.48
Today's Range 63.48 - 63.48
52wk Range 58.30 - 63.49
Shares Outstanding 170,341,553
Dividend Yield N/A
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
Novo Nordisk Navigates a GLP-1 Gold Rush: Soaring Obesity Drug Sales Clash with Revised Outlook Amidst Mounting Competition
September 16, 2025
Copenhagen, Denmark – Pharmaceutical giant Novo Nordisk (NYSE: NVO) has reported a robust second quarter for 2025, with impressive revenue and net income figures largely propelled by the formidable... 
Via MarketMinute
Topics Earnings Economy Intellectual Property
FDA Flags Alarming Contamination At Novo Nordisk Indiana Plant, Including Cat Hair, Bacteria, And Foreign Particles
August 25, 2025
Novo Nordisk's acquired facility faces scrutiny over recurring contamination, incomplete investigations, and ineffective corrective actions. 
Via Benzinga

Performance

YTD
N/A
N/A
1 Month
N/A
N/A
3 Month
N/A
N/A
6 Month
N/A
N/A
1 Year
+5.3%
+5.3%

More News

Read More
Catalent Announces New Board Appointments
February 20, 2025
From Catalent, Inc.
Via Business Wire
Lennox To Join S&P 500 Index, Replacing Catalent
December 18, 2024
Via Investor's Business Daily
Topics Artificial Intelligence Stocks
Novo Holdings Completes Acquisition of Catalent
December 18, 2024
From Catalent, Inc.
Via Business Wire
Ozempic Maker Novo Nordisk Invests Over $1 Billion In New Denmark Production Facility, Closer To Add 3 More From Catalent
December 16, 2024
Via Benzinga
Catalent and Novo Holdings Fulfill All Regulatory Closing Conditions for Pending Transaction
December 14, 2024
From Catalent, Inc.
Via Business Wire
Catalent and Novo Holdings Receive European Commission Unconditional Approval for Pending Transaction
December 06, 2024
From Catalent, Inc.
Via Business Wire
The Weight-Loss Battle That Could Rattle Eli Lilly's $100 Billion Market
December 05, 2024
Via Investor's Business Daily
Catalent, Inc. Reports First Quarter Fiscal 2025 Results
November 05, 2024
From Catalent, Inc.
Via Business Wire
Roche's Q3 Sales Surge Led By Ocrevus, Vabysmo, Urges Regulators To Block Novo Holdings' $16.5B Catalent Acquisition
October 23, 2024
Via Benzinga
Catalent Issues Open Letter to Customers Regarding Pending Acquisition by Novo Holdings
October 21, 2024
From Catalent, Inc.
Via Business Wire
After US Senator, Unions Urge Federal Trade Commission To Block Novo's $16.5B Acquisition Of Catalent
October 18, 2024
Via Benzinga
Jim Cramer: 'We Need More Uranium,' Recommends This Stock; Says Novo Nordisk 'Doesn't Hold A Candle' To Big Pharma Rival
October 15, 2024
Via Benzinga
Catalent Signs Agreement to Sell Somerset, NJ Oral Solids Facility
October 14, 2024
From Catalent, Inc.
Via Business Wire
FTC Faces Pressure to Block Novo Nordisk-Catalent Merger Over Antitrust Fears
October 10, 2024
Via Benzinga
Four Stocks To Watch This Week - Tuesday, Oct. 01
October 01, 2024
Via Talk Markets
Tempus AI Stock Clears Technical Benchmark, Hitting 80-Plus RS Rating
September 16, 2024
Via Investor's Business Daily
Topics Artificial Intelligence
Catalent, Inc. Reports Fourth Quarter and Fiscal 2024 Results
August 29, 2024
From Catalent, Inc.
Via Business Wire
Prediction: Up 74% So Far This Year, This Weight Loss Stock Is About to Crater
August 16, 2024
Via The Motley Fool
Catalent Completes $25 Million Expansion of its Clinical Supply Facility in Schorndorf, Germany
July 16, 2024
From Catalent, Inc.
Via Business Wire
Sarepta's Expanded Approval Unlikely To Influence Novo Holdings' Acquisition of Catalent, But Provides Investor Protection Amid Uncertainty
June 21, 2024
Via Benzinga
S&P 500 Giants Lead Five Healthy Stocks Near Buy Points
June 01, 2024
Via Investor's Business Daily
Topics Stocks
Catalent Stockholders Approve Transaction with Novo Holdings
May 29, 2024
From Catalent, Inc.
Via Business Wire
Soaring Eli Lilly Stock Could Climb Another 24% According to a Wall Street Analyst. Is the Stock a Buy Now?
May 28, 2024
Via The Motley Fool

Frequently Asked Questions

Is Catalent, Inc. Common Stock publicly traded?
Yes, Catalent, Inc. Common Stock is publicly traded.
What exchange does Catalent, Inc. Common Stock trade on?
Catalent, Inc. Common Stock trades on the New York Stock Exchange
What is the ticker symbol for Catalent, Inc. Common Stock?
The ticker symbol for Catalent, Inc. Common Stock is CTLT on the New York Stock Exchange
What is the current price of Catalent, Inc. Common Stock?
The current price of Catalent, Inc. Common Stock is 63.48
When was Catalent, Inc. Common Stock last traded?
The last trade of Catalent, Inc. Common Stock was at 12/17/24 07:00 PM ET
What is the market capitalization of Catalent, Inc. Common Stock?
The market capitalization of Catalent, Inc. Common Stock is 10.81B
How many shares of Catalent, Inc. Common Stock are outstanding?
Catalent, Inc. Common Stock has 11B shares outstanding.
FinancialContent
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.

Having difficulty making your payments? We're here to help! Call 1-800-255-5897

Copyright © 2019 Franklin Credit Management Corporation
All Rights Reserved
Contact Us | Privacy Policy | Terms of Use | Sitemap